Wall St. edges higher as tech boost counters losses in bank stocks

Wall St. edges higher as tech boost counters losses in bank stocks
(Reuters) – U.S. stocks eked out gains on Thursday as declines in financial stocks after the Federal Reserve’s move to not raise interest rates this year were countered by gains in technology companies. FILE PHOTO: Traders work on the floor at the New York Stock Exchange (NYSE) in New York, U.S., March 20, 2019. REUTERS/Brendan McDermid Having downgraded their U.S.... Read More

Exclusive: Sanofi says working on CEO succession plan

Exclusive: Sanofi says working on CEO succession plan
PARIS (Reuters) – Pharmaceuticals group Sanofi is working on a plan to find a new CEO in agreement and consultation with current chief executive Olivier Brandicourt, a spokesman for the French drugmaker told Reuters on Monday. FILE PHOTO: The logo of Sanofi is pictured during the Viva Tech start-up and technology summit in Paris, France, May 25, 2018. REUTERS/Charles Platiau... Read More

Wall Street sinks for third day as healthcare, energy slump

Wall Street sinks for third day as healthcare, energy slump
(Reuters) – Wall Street’s main indexes fell for a third session on Wednesday, with the S&P 500 posting its biggest one-day decline in a month, as healthcare and energy shares slumped and investors sought reasons to buy after the market’s strong rally to start the year. FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE)... Read More

Wall Street falls for third day as healthcare, energy slump

Wall Street falls for third day as healthcare, energy slump
(Reuters) – Wall Street’s main indexes fell for a third session on Wednesday as healthcare and energy shares slumped and investors sought reasons to buy after the market’s strong rally to start the year. FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., March 4, 2019. REUTERS/Brendan McDermid With corporate earnings... Read More

Wall Street eyes third day of losses as healthcare sector weighs

Wall Street eyes third day of losses as healthcare sector weighs
(Reuters) – Wall Street’s three main indexes were on track to record their third session of losses as healthcare stocks fell and investors booked profits after a stellar run in equities this year. FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., March 4, 2019. REUTERS/Brendan McDermid The S&P 500 has... Read More

Intellia CEO not involved in Starboard’s Bristol-Myers board challenge

Intellia CEO not involved in Starboard’s Bristol-Myers board challenge
NEW YORK (Reuters) – Intellia Therapeutics Inc Chief Executive John Leonard, who U.S. drug maker Bristol-Myers Squibb Co said last week was nominated by hedge fund Starboard Value LP to sit on its board, is not affiliated with the effort, an Intellia spokeswoman said on Thursday. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse... Read More

U.S. stocks edge downward as Wall Street takes a pause

U.S. stocks edge downward as Wall Street takes a pause
NEW YORK (Reuters) – Wall Street’s main indexes fell slightly on Thursday as support from better-than-feared U.S. GDP data was countered by concerns about earnings and U.S.-China trade relations. Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., February 25, 2019. REUTERS/Brendan McDermid Also on Thursday, President Donald Trump said he had walked... Read More

Starboard joins opposition to Bristol-Myers’ $74 billion Celgene deal

Starboard joins opposition to Bristol-Myers’ $74 billion Celgene deal
(Reuters) – Activist hedge fund Starboard Value LP followed Bristol-Myers Squibb Co’s second-largest investor, Wellington Management, in opposing the drugmaker’s $74 billion purchase of biotech Celgene Corp on Thursday, sowing further doubt on would be the largest pharmaceutical acquisition of all time. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in... Read More

Wall Street flat; strong GDP counters Trump-Kim summit failure

Wall Street flat; strong GDP counters Trump-Kim summit failure
NEW YORK (Reuters) – Wall Street’s main indexes went nowhere fast on Thursday with better-than-feared GDP data providing some support to counter the abrupt end to a U.S.-North Korean summit and ongoing concerns about earnings and U.S.-China trade relations. Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., February 25, 2019. REUTERS/Brendan McDermid... Read More

Wall Street muted after Trump-Kim summit ends early, GDP data

Wall Street muted after Trump-Kim summit ends early, GDP data
(Reuters) – Wall Street’s main indexes struggled for direction on Thursday as an abrupt end to a U.S.-North Korean summit and a clutch of weak earnings hit sentiment, with a better-than-feared GDP data offering some support. Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., February 25, 2019. REUTERS/Brendan McDermid President Donald Trump... Read More